Browsing Tag
Vivek Sharma
3 posts
Suven Pharmaceuticals acquires majority stake in NJ Bio, strengthens US presence
Suven Pharmaceuticals Limited, a technology-focused contract development and manufacturing organisation (CDMO), has announced the acquisition of a controlling…
Suven Pharmaceuticals reports 12% revenue growth for Q2 with strong outlook
Suven Pharmaceuticals Ltd. (BSE: 530239, NSE: SUVENPHARM), a technology-focused Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad,…
CLSA sees major drop ahead for Ambuja Cements – Investors beware!
CLSA, a global brokerage firm, has maintained an ‘Underperform’ rating for Ambuja Cements Limited, predicting a potential 9%…